Atara Biotherapeutics (ATRA) Other Working Capital Changes (2013 - 2026)
Atara Biotherapeutics' (ATRA) quarterly Other Working Capital Changes came in at -$109000.0 in Q2 2025, down 199.09% on a QoQ basis from $110000.0 in Q1 2025.
Atara Biotherapeutics (ATRA) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Atara Biotherapeutics (ATRA) has 7 years of Other Working Capital Changes data on file, last reported at -$109000.0 in Q2 2025.
- Quarterly Other Working Capital Changes changed N/A year-over-year to -$109000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$109000.0 (up 69.03% YoY) and the FY2025 annual result came in at $1000.0, up 100.22% from the prior year.
- Other Working Capital Changes slipped to -$109000.0 in Q2 2025, from $110000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $79.1 million in Q2 2025 to a low of -$79.1 million in Q1 2025.
- A 5-year average of -$1.4 million and a median of -$273000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 377.27% in 2023, down 204.08% in 2023.
- Tracing ATRA's Other Working Capital Changes over 5 years: stood at -$710000.0 in 2021, then soared by 115.49% to $110000.0 in 2022, then slumped by 69.09% to $34000.0 in 2023, then plunged by 1458.82% to -$462000.0 in 2024, then surged by 76.41% to -$109000.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$109000.0 (Q2 2025), $110000.0 (Q1 2025), and -$462000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - |
| 10 | Atara Biotherapeutics | 139.81 Mn | 123.25 Mn | 439,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -211,000.00 |
| Jun 30, 2026 | -211,000.00 |
| Jun 30, 2026 | -211,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 4.89 Mn |
| Dec 31, 2025 | 4.89 Mn |
| Dec 31, 2025 | 4.89 Mn |
| Sep 30, 2025 | -4.91 Mn |
| Sep 30, 2025 | -4.91 Mn |
| Sep 30, 2025 | -4.91 Mn |
| Jun 30, 2025 | 79.11 Mn |
| Jun 30, 2025 | 79.11 Mn |
| Jun 30, 2025 | 79.11 Mn |
| Mar 31, 2025 | -79.11 Mn |
| Mar 31, 2025 | -79.11 Mn |
| Mar 31, 2025 | -79.11 Mn |
| Dec 31, 2024 | -273,000.00 |
| Dec 31, 2024 | -273,000.00 |